Related Experiment Videos
Association of Alzheimer's genetic loci with mild behavioral impairment
Shea J Andrews1,2, Zahinoor Ismail3,4,5, Kaarin J Anstey6,7,2
1Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract:
Mild behavioral impairment (MBI) describes the emergence of later-life neuropsychiatric symptoms (NPS) as an at-risk state for incident cognitive decline and dementia, and for some as a potential manifestation of prodromal dementia. How NPS mechanistically link to the development of mild cognitive impairment and Alzheimer's disease (AD) is not fully understood, with potential mechanisms including shared risk factors related to both NPS and cognitive impairment, or AD pathology promoting NPS. This is the first exploratory study to examine whether AD genetic loci as a genetic risk score (GRS), or individually, are a shared risk factor with MBI. Participants were 1,226 older adults (aged 72-79; 738 males; 763 normal cognition) from the Personality and Total Health Through Life project. MBI was approximated in accordance with Criterion 1 of the ISTAART-AA diagnostic criteria using a transformation algorithm for the neuropsychiatric inventory. A GRS was constructed from 25 AD risk loci. Binomial logistic regression adjusting for age, gender, and education examined the association between GRS and MBI. A higher GRS and APOE*ε4 were associated with increased likelihood of affective dysregulation. Nominally significant associations were observed between MS4A4A-rs4938933*C and MS4A6A-rs610932*G with a reduced likelihood of affective dysregulation; ZCWPW1-rs1476679*C with a reduced likelihood of social inappropriateness and abnormal perception/thought content; BIN1-rs744373*G and EPHA1-rs11767557*C with higher likelihood of abnormal perception/thought content; NME8-rs2718058*G with a reduced likelihood of decreased motivation. These preliminary findings suggest a common genetic etiology between MBI and traditionally recognized cognitive problems observed in AD and improve our understanding of the pathophysiological features underlying MBI.
Insights
This study explored if Alzheimer's disease (AD) genetic risk factors are linked to mild behavioral impairment (MBI). Findings suggest a shared genetic basis between MBI and cognitive decline, improving understanding of AD
Area of Science:
- Neuroscience
- Genetics
- Gerontology
Background:
- Mild behavioral impairment (MBI) comprises later-life neuropsychiatric symptoms (NPS) indicating risk for cognitive decline and dementia.
- The mechanistic link between NPS and mild cognitive impairment (MCI) or Alzheimer's disease (AD) remains unclear, with possibilities including shared risk factors or AD pathology driving NPS.
- This study is the first to investigate AD genetic loci as a shared risk factor for MBI.
Purpose of the Study:
- To explore the association between a genetic risk score (GRS) derived from AD risk loci and MBI.
- To examine individual AD genetic loci for their association with MBI.
- To enhance understanding of the pathophysiological features underlying MBI.
Main Methods:
- Utilized data from 1,226 older adults (aged 72-79) from the Personality and Total Health Through Life project.
- Approximated MBI using a transformation algorithm for the neuropsychiatric inventory based on ISTAART-AA diagnostic criteria.
- Constructed a GRS from 25 AD risk loci and employed binomial logistic regression, adjusting for age, gender, and education.
Main Results:
- A higher GRS and the APOE*ε4 allele were associated with an increased likelihood of affective dysregulation.
- Specific genetic loci showed nominal associations with reduced or increased likelihood of MBI symptom clusters, including affective dysregulation, social inappropriateness, abnormal perception/thought content, and decreased motivation.
- Preliminary findings indicate potential shared genetic etiology between MBI and AD-related cognitive issues.
Conclusions:
- Suggests a common genetic etiology between MBI and cognitive problems characteristic of AD.
- Provides initial evidence supporting the role of AD genetic risk factors in the development of MBI.
- Improves understanding of the underlying pathophysiological mechanisms of MBI.